Sold out of itself: management is turning demand away today because the company cannot supply it, and the fix is already
The model's full reasoning — Q2 2023 call → NOWe need to analyze the transcript for the three conditions. The question asks if management describes that the company is CURRENTLY FAILING TO SERVE DEMAND IT ALREADY HAS, with real identified buyers being turned away, made to wait, etc., due to the company's own inability to supply, and that management is already spending/committing to remove that limit. Let's parse the transcript. The company is Akoya Biosciences, spatial biology instruments. They report record revenue, record system placements. They discuss various product launches, upgrades. There's mention of supply chain challenges, inventory charges, etc. I need to look for statements about unserved demand. They talk about product launches, field upgrades, reagent panels. They discuss improving workflow and throughput. But do they explicitly state that they are turning away buyers or that demand exceeds their ability to supply? They mention "supply chain challenges" and inventory expiration, but that's about materials they buy. They also mention "we continue to see tailwinds" and growth. They discuss operational efficiencies, reducing costs, etc. Let's go through key parts. Brian says: "We continue to make great progress in the downstream, translational, and clinical markets." That's not about unserved demand. He mentions "CRO network amplifies Akoya's presence" but that's about partnerships. They talk about "targeted investments" and "streamlining cost structure." On gross margin, they had a $2 million charge for expired materials. That's about inventory. On the Fusion 2.0 upgrade: "Field upgrades started with our first customers in June and we expect a significant percentage of our PhenoCycler-Fusion customers to upgrade by year-end." That's about capacity improvement, but not about turning away customers. They say "The upgrade also includes the necessary hardware and software components to support RNA Enablement." No mention of backlog. They discuss reagent revenue growth and pull-through. They mention "annualized second quarter reagent pull-through has now increased to the mid-$30,000 range" and "we anticipate annual reagent revenue growth to be in this range for the next several years." That's about growth, not unserved demand. Question: Does management describe actual buyers being turned away? No.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| ZBH | Zimmer Biomet Holdings, Inc. | Q2 2017 | 2017-07-30 | F |
OGI · Q3 2022 → YESThe question is: Does management describe that the company is CURRENTLY FAILING TO SERVE DEMAND IT ALREADY HAS — real buyers being turned away, etc., because they can't supply, AND already spending or...YES The transcript shows management describing a current situation where demand is outstripping supply ("we have been really tight on our supply. Our demand was outstripping our supply"), leading to turning away or limiting sales to certain provinces ("we were really stealing from 1 pocket to the other as we're trying to balance the demand to what available capacity we had" and limiting SHRED distribution). This is material, as it affects their ability to serve existing customers fully.
CRL · Q2 2022 → YESThe question is whether management describes the company currently failing to serve demand it already has, and already spending or committing to remove that limit. YES The transcript shows clients securing space in take-or-pay arrangements because of tight capacity, indicating unserved demand from existing buyers. Management notes capacity is well utilized and they are hiring staff to accommodate higher forecasted demand, confirming they are already acting to close the gap. This situation is material given the backlog growth and emphasis on availability over price.
BRBR · Q4 2023 → YESThe question is whether management describes the company currently failing to serve demand it already has, and already spending or committing to remove that limit. NO The transcript shows ongoing capacity constraints and tight supply dynamics, with management noting they are holding back on marketing/promotions due to limited supply and that they lost customers in prior years due to capacity.